Concerning the diagnostic aspect, the morphology of tumor cells and other immunhistochemical markers, such as chromogranin A, neuro-specific enolase (NSE), CD57 or CD56, are sufficient to enable the diagnosis of small cell cancer with neuroendocrine differentiation. This evidence concerns the gene ENO2 and neoplasm.